Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence? (Q34349506)

1 August 2017

1 reference

title

Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence? (English)

1 reference

1 August 2017

0 references

Walker BR

1

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Growth Hormone & I G F Research

1 August 2017

published in

1 reference

1 August 2017

volume

11 Suppl A

1 reference

1 August 2017

page(s)

S91-5

1 reference

Perturbations of the hypothalamic-pituitary-adrenal axis and the metabolic syndrome in ageing

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

A role for insulin in the aetiology and course of hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Increased glucocorticoid activity in men with cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Glucocorticoid exposure in utero: new model for adult hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Maintenance of maternal diet-induced hypertension in the rat is dependent on glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

The effect of metabolic programming on atherosclerosis and obesity risk factors in UK adolescents living in poor socioeconomic areas

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Size at birth and adrenocortical function in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Cortisol secretion in relation to body fat distribution in obese premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Cortisol production in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Obesity and gender influence cortisol secretion and metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Cortisol effects on body mass, blood pressure, and cholesterol in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Does central obesity reflect "Cushing's disease of the omentum"?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980015-0

7 January 2021

10.1016/S1096-6374(01)80015-0

Identifiers

DOI

1 reference

1 August 2017

1 reference